Assignee
Sciencons AS
NO·10 granted patents·8 pending applications·24 citations·filing 2015–2025
Top patents by PatentIndex Score
18 records- 0196US12249437B2Production of highly purified 212PBSciencons AS·Filed 2024·Granted Mar 11, 2025·3 cites·38 claims
- 0296US12125603B2Production of highly purified 212PbSciencons AS·Filed 2020·Granted Oct 22, 2024·4 cites·20 claims
- 0395US10434198B2Radiopharmaceutical solutions with advantageous propertiesSciencons AS·Filed 2016·Granted Oct 8, 2019·10 cites·14 claims
- 0491US9433690B1Radiopharmaceutical solutions with advantageous propertiesSciencons AS·Filed 2015·Granted Sep 6, 2016·5 cites·8 claims
- 0589US12394533B2Production of highly purified 212PBSciencons AS·Filed 2024·Granted Aug 19, 2025·0 cites·30 claims
- 0689US2025336557A1Production of highly purified 212pbSciencons AS·Filed 2025·Application pending·0 cites
- 0789US2025336558A1Production of highly purified 212pbSciencons AS·Filed 2025·Application pending·0 cites
- 0889US2025336559A1Production of highly purified 212pbSciencons AS·Filed 2025·Application pending·0 cites
- 0988US10377778B2Lead and thorium compoundsSciencons AS·Filed 2018·Granted Aug 13, 2019·2 cites·13 claims
- 1088US2025210212A1Production Of Highly Purified 212PBSciencons AS·Filed 2024·Application pending·0 cites
- 1188US2025201434A1Production of Highly Purified 212PBSciencons AS·Filed 2024·Application pending·0 cites
- 1288US2025210211A1Production of highly purified 212pbSciencons AS·Filed 2024·Application pending·0 cites
- 1387US12567511B2Production of highly purified 212PBSciencons AS·Filed 2024·Granted Mar 3, 2026·0 cites·32 claims
- 1482US12406776B2Production of highly purified 212PbSciencons AS·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1582US12297218B2Complex comprising a PSMA-targeting compound linked to a lead or thorium radionuclideSciencons AS·Filed 2023·Granted May 13, 2025·0 cites·20 claims
- 1677US2024247011A1Complex comprising a psma-targeting compound linked to a lead or thorium radionuclideSciencons AS·Filed 2024·Application pending·0 cites
- 1761US2025099631A1Complexes for cancer treatment and imagingSciencons AS·Filed 2023·Application pending·0 cites
- 1851US11306038B2Preparation of 212Pb labeled monoclonal antibodiesSciencons AS·Filed 2017·Granted Apr 19, 2022·0 cites·15 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →